Use of an Electrochemically Synthesised Metabolite of a Selective Androgen Receptor Modulator for Mass Spectrometry-Based Sports Drug Testing

Abstract

The elucidation of the metabolism of new therapeutics is a major task for pharmaceutical companies and of great interest for drug testing laboratories. The latter in particular need to determine the presence or absence of drugs or their metabolic products in urine to test for a misuse of these compounds. Commonly, in vitro or animal models are used to mimic the human metabolism and produce potential targets in amounts allowing for method development. An alternative route based on electrochemical reactions of drugs was reported to allow for the generation of selected metabolites. The utility of this approach for doping control purposes was demonstrated with a novel class of anabolic agents termed selective androgen receptor modulators (SARMs). An arylpropionamide-derived drug candidate was subjected to electrochemical “metabolism” and a major phase-I-metabolite, resulting from the elimination of a substituted phenol residue as identified in in vitro experiments, was generated and characterised using liquid chromatography/nuclear magnetic resonance spectroscopy and high resolution/high accuracy mass spectrometry. The metabolite was included in routine doping control procedures based on liquid chromatography/tandem mass spectrometry and has served as a reference compound for 5000 doping control specimens.

Keywords

sport doping mass spectrometry SARM Ostarine

Get full access to this article

View all access options for this article.

References

Catlin

D.H.

Ahrens

B.D.

and Kucherova

, “Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine”, Rapid Commun. Mass Spectrom. 16, 1273 (2002). doi: 10.1002/rcm.722

Catlin

D.H.

Sekera

M.H.

Ahrens

B.D.

Starcevic

Chang

Y.-C.

and Hatton

C.K.

, “Tetrahydrogestrinone: Discovery, synthesis, and detection in urine”, Rapid Commun. Mass Spectrom. 18, 1245 (2004). doi: 10.1002/rcm.1495

Sekera

M.H.

Ahrens

B.D.

Chang

Y.C.

Starcevic

Georgakopoulos

and Catlin

D.H.

, “Another designer steroid: Discovery, synthesis, and detection of ‘madol’ in urine”, Rapid Commun. Mass Spectrom. 19, 781 (2005). doi: 10.1002/rcm.1858

Breidbach

and Catlin

D.H.

, “RSR13, a potential athletic performance enhancement agent: Detection in urine by gas chromatography/mass spectrometry”, Rapid Commun. Mass Spectrom. 15, 2379 (2001). doi: 10.1002/rcm.523

Thevis

Krug

and Schänzer

, “Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry”, J. Mass Spectrom. 41, 332 (2006). doi: 10.1002/jms.993

Thevis

, and Schänzer

, “Emerging Drugs—Potential for misuse in sport and doping control detection strategies”, Mini-Rev. Med. Chem. 7, 533 (2007). doi: 10.2174/138955707780619590

Levesque

J.F.

Templeton

Trimble

Berthelette

and Chauret

, “Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes”, Anal. Chem. 77, 3164 (2005). doi: 10.1021/ac050150y

Kuuranne

Leinonen

Schänzer

Kamber

Kostiainen

and Thevis

, “Aryl-propionamide-derived selective androgen receptor modulators: LC-MS/MS characterization of the in vitro synthesized metabolites for doping control purposes”, Drug Metab. Dispos. 36, 571 (2008). doi: 10.1124/dmd.107.017954

Botre

, “Drugs of abuse and abuse of drugs in sportsmen: The role of in vitro models to study effects and mechanisms.” Toxicol. In Vitro 17, 509 (2003). doi: 10.1016/S0887-2333(03)00120-6

10.

Levesque

Gaudreault

Houle

and Chauret

, “Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective”, J. Chromatogr. B 780, 145 (2002). doi: 10.1016/S1570-0232(02)00444-0

11.

Lohmann

and Karst

, “Biomimetic modeling of oxidative drug metabolism: Strategies, advantages and limitations”, Anal Bioanal Chem 391, 79 (2008). doi: 10.1007/s00216-007-1794-x

12.

Karst

, “Electrochemistry/mass spectrometry (EC/MS)—a new tool to study drug metabolism and reaction mechanisms”, Angew. Chem. Int. Ed. 43, 2476 (2004). doi: 10.1002/anie.200301763

13.

Permentier

H.P.

Bruins

A.P.

and Bischoff

, “Electrochemistry-mass spectrometry in drug metabolism and protein research”, Mini-Rev. Med. Chem. 8, 46 (2008). doi: 10.2174/138955708783331586

14.

Hambitzer

and Heitbaum

, “Electrochemical thermospray mass spectrometry”, Anal. Chem. 58, 1067 (1986). doi: 10.1021/ac00297a019

15.

Volk

K.J.

Lee

M.S.

Yost

R.A.

and Brajter-Toth

, “Electrochemistry/Thermospray/Tandem Mass Spectrometry in the Study of Biooxidation of Purines”, Anal. Chem. 60, 720 (1988). doi: 10.1021/ac00158a025

16.

Zhou

and Van Berkel

G.J.

, “Electrochemistry combined on-line with electrospray mass spectrometry”, Anal. Chem. 67, 3643 (1995). doi: 10.1021/ac00116a005

17.

Getek

T.A.

Korfmacher

W.A.

McRae

T.A.

and Hinson

J.A.

, “Utility of solution electrochemistry mass spectrometry for investigating the formation and detection of biologically important conjugates of acetaminophen”, J. Chromatogr. 245 (1989). doi: 10.1016/S0021-9673(01)93919-6

18.

van Leeuwen

S.M.

Blankert

Kauffmann

J.M.

and Karst

, “Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry”, Anal. Bioanal. Chem. 382, 742 (2005). doi: 10.1007/s00216-005-3053-3

19.

Lohmann

and Karst

, “Simulation of the detoxification of paracetamol using on-line electrochemistry/liquid chromatography/mass spectrometry”, Anal. Bioanal. Chem. 386, 1701 (2006). doi: 10.1007/s00216-006-0801-y

20.

Johansson

Weidolf

and Jurva

, “Mimicry of phase I drug metabolism—novel methods for metabolite characterization and synthesis”, Rapid Commun. Mass Spectrom. 21, 2323 (2007). doi: 10.1002/rcm.3077

21.

Jurva

Wikstrom

H.V.

and Bruins

A.P.

, “In vitro mimicry of metabolic oxidation reactions by electrochemistry/mass spectrometry”, Rapid Commun. Mass Spectrom. 14, 529 (2000). doi: 10.1002/(SICI)1097-0231(20000331)14:6<529::AID-RCM904>3.0.CO;2-H

22.

Jurva

Wikstrom

H.V.

Weidolf

and Bruins

A.P.

, “Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions”, Rapid Commun. Mass Spectrom. 17, 800 (2003). doi: 10.1002/rcm.978

23.

Tahara

Yano

Kanagawa

Abe

Yamada

Iijima

Mochizuki

and Nishikawa

, “Successful preparation of metabolite of troglitazone by in-flow electrochemical reaction on coulometric electrode”, Chem. Pharm. Bull. 55, 1207 (2007). doi: 10.1248/cpb.55.1207

24.

Jurva

Holmen

Grönberg

Masimirembwa

and Weidolf

, “Electrochemical generation of electrophilic drug metabolites: Characterization of amodiaquine quinoneimine and cysteinyl conjugates by MS, IR, and NMR”, Chem. Res. Toxicol. 21, 928 (2008). doi: 10.1021/tx700400c

25.

Madsen

K.G.

Skonberg

Jurva

Cornett

Hansen

S.H.

Johansen

T.H.

and Olsen

, “Bioactivation of diclofenac in vitro and in vivo: correlation to electrochemical studies”, Chem. Res. Toxicol. 21, 1107 (2008). doi: 10.1021/tx700419d

26.

World Anti-Doping Agency, “The 2008 Prohibited List”, http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf , 28-11-2007

27.

Thevis

Kamber

and Schänzer

, “Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes”, Rapid Commun. Mass Spectrom. 20, 870 (2006). doi: 10.1002/rcm.2389

28.

Thevis

Kohler

Maurer

Schlörer

Kamber

and Schänzer

, “Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis”, Rapid Commun. Mass Spectrom. 21, 3477 (2007). doi: 10.1002/rcm.3247

29.

Thevis

Kohler

Thomas

Maurer

Schlörer

Kamber

and Schänzer

, “Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS”, Anal. Bioanal. Chem. 391, 251 (2008). doi: 10.1007/s00216-008-1882-6

30.

Lohmann

and Karst

, “Generation and identification of reactive metabolites by electrochemistry and mmobilized enzymes coupled on-line to liquid chromatography/mass spectrometry”, Anal. Chem. 79, 6831 (2007). doi: 10.1021/ac071100r

31.

Marhefka

C.A.

Gao

Chung

Kim

Yin

Bohl

Dalton

J.T.

and Miller

D.D.

, “Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators”, J. Med. Chem. 47, 993 (2004). doi: 10.1021/jm030336u

32.

Tucker

and Chesterson

G.J.

, “Resolution of the nonsteroidal antiandrogen 4′-cyano-3-[(4-fluorophenyl) sulfonyl]-2-hydroxy-2-methyl-3′- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer”, J. Med. Chem. 31, 885 (1988). doi: 10.1021/jm00399a034

33.

Tucker

Crook

J.W.

and Chesterson

G.J.

, “Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides”, J. Med. Chem. 31, 954 (1988). doi: 10.1021/jm00400a011

34.

Thevis

Sigmund

Koch

and Schänzer

, “Determination of tuaminoheptane in doping control urine samples”, Eur. J. Mass Spectrom. 13, 213 (2007). doi: 10.1255/ejms.875

35.

Thevis

and Schänzer

, “Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: Ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins”, J. Chromatogr. Sci. 43, 22 (2005).